CSIMarket Company Name, Ticker, Competitors, else..
 
Sera Prognostics Inc   (NASDAQ: SERA)
Other Ticker:  
 
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare
 
Price: $4.2900 $0.26 6.452%
Day's High: $4.3388 Week Perf: -8.92 %
Day's Low: $ 4.08 30 Day Perf: -32.23 %
Volume (M): 176 52 Wk High: $ 12.36
Volume (M$): $ 755 52 Wk Avg: $7.83
Open: $4.08 52 Wk Low: $3.84



 Market Capitalization (Millions $) 144
 Shares Outstanding (Millions) 34
 Employees 46
 Revenues (TTM) (Millions $) 0
 Net Income (TTM) (Millions $) -32
 Cash Flow (TTM) (Millions $) -7
 Capital Exp. (TTM) (Millions $) 1

Sera Prognostics Inc
Sera Prognostics Inc is a biotechnology company that specializes in developing diagnostic tests for predicting the risk of preterm birth and other pregnancy-related complications. The company utilizes advanced proteomic technologies to analyze protein biomarkers found in maternal blood samples. By measuring these biomarkers, Sera Prognostics aims to provide healthcare professionals with valuable information to guide personalized medical interventions and improve the outcomes of high-risk pregnancies. Their main product is the PreTRM test, which is designed to assess the risk of preterm delivery up to 12 weeks before symptoms occur. Sera Prognostics is dedicated to advancing the field of women's health and reducing the incidence of preterm birth through their innovative diagnostic solutions.


   Company Address: 2749 East Parleys Way Salt Lake City 84109 UT
   Company Phone Number: 990-0520   Stock Exchange / Ticker: NASDAQ SERA


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
EXAS   -7.26%    
FLGT   -2.11%    
FTRE   -4.61%    
GH        4.14% 
NTRA   -1.82%    
VCYT   -7.17%    
• View Complete Report
   



Sera Prognostics Inc

SERA's Impressive Progress in First Quarter of 2024 Mirrors Previous Success



Sera Prognostics Inc, known as The Pregnancy Company, recently released its financial results for the first quarter of 2024. The company, focused on enhancing maternal and neonatal health through innovative pregnancy biomarker information, showcased significant progress compared to the same period last year. In this article, we will delve into the details of their Q1 2024 earnings report and analyze the data in the context of their overall financial performance.
Earnings Report Analysis:
During the first quarter of 2024, Sera Prognostics Inc reported a loss of $-0.25 per share, showcasing an improvement from the $-0.34 loss per share from the same period in the previous year. This indicates a positive trend towards profitability, as the company managed to reduce its loss margin. Additionally, when compared to the previous reporting period, the earnings per share remained stable at $-0.25.
Sera Prognostics Inc

Despite Stock Growth, Sera Prognostics Inc Faces Financial Challenges in Latest Fiscal Period



Sera Prognostics Inc, a renowned medical laboratory specializing in improving maternal and neonatal health through innovative pregnancy biomarker information, recently announced its financial results for the fourth quarter of 2023. While the company's stock underwent a slight drop over the last five trading days, it still reflects an impressive 83.94% increase over the past 90 days. Additionally, Sera Prognostics Inc's stock is currently trading on NASDAQ, exhibiting a significant 129.7% value above its 52-week average.
Financial Results:
Sera Prognostics Inc's financial report for the fiscal period ending December 31, 2023, revealed several challenges. The company experienced a staggering 36.923% decline in revenue to $0.04 million and recorded a shortfall per share of $-0.25 compared to $-0.26 in the previous year. This indicates a persistent decrease in revenue and profitability, highlighting the need for strategic changes.
Sera Prognostics Inc

Revitalizing Growth: Sera Prognostics Inc Breaks Free from Diminishing Returns



Sera Prognostics Inc, a leading player in the Medical Laboratories industry, recently released its financial results for the July to September 2023 period. Despite witnessing a decline in revenue, the company managed to reduce its loss per share, showcasing its ability to improve its financial position. Let's examine these results in the context of the stock performance and industry trends.
Improved Loss per Share:
During the reported period, Sera Prognostics Inc recorded a loss per share of $-0.23, which marks a significant improvement compared to the loss of $-0.35 per share reported in the same period a year ago. This positive development indicates that the company has made progress towards profitability and is effectively managing its expenses.
Sera Prognostics Inc

Sera Prognostics Inc Reports Significant Loss of $-0.34 per Share in Latest Fiscal Period, Raises Concerns Over Company's Financial Performance

In the most recent fiscal period, Sera Prognostics Inc experienced a loss of $0.34 per share, an improvement from the previous year's loss of $0.37 per share and matching the loss from the previous reporting season. Although the company's earnings are still in negative territory, this trend towards lower losses is a positive sign for investors.
On the revenue front, Sera Prognostics Inc saw a significant increase of 57.692% to $0.12 million from the same period the previous year. Sequentially, the company's revenue grew by 23% from $0.10 million. This growth in revenue is quite impressive, especially when compared to its peers in the Medical Laboratories sector, as most companies in this industry reported an average revenue growth of only 3.66% in the second quarter of 2023 compared to the same period in the previous year.






Sera Prognostics Inc's Segments





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com